I commend Representative Yoho for holding this Special Order on executive overreach. As a lifelong healthcare professional and former businessowner, I believe the healthcare industry is flooded with examples of President Obama's administration overreaching its authority and either ignoring congressional intent or refusing to enforce laws enacted by Congress. As recent as last Monday, April 18, the FDA issued new guidance related to the Drug Quality and Security Act and compounding pharmacists. On November 27, 2013, President Obama signed the Drug Quality and Security Act, DQSA, into law. Within the DQSA, several important provisions were related to the oversight of compounding human medications. In fact, DQSA created two types of compounding pharmacies, 503A pharmacies and 503B pharmacies. 503A compounding pharmacies are small, community pharmacies that only compound small quantities of medication to a very limited number of doctors and patients with very specific needs. A perfect example of this is a servicemember who has lost a limb in war. Some servicemen and -women who have lost their limbs experience significant amounts of pain that regular medication does not adequately address. Compounded medication helps with this specialized need. 503B compounding facilities are those outsourcing facilities that manufacture compounded medications and ship them all over the country.…
Share
More from John Rice Carter
I thank the gentleman for yielding. Mr. Speaker, I rise today in strong support of the bipartisan Maternal and Child Health Stillbirth Prevention Act. As a father to three sons and a grandfather to seven beautiful grandbabies, there is…
I thank the gentleman for yielding. Mr. Speaker, I rise today in strong support of the Stop Institutional Child Abuse Act, which I am proud to lead with Senator Merkley and Representative Khanna. Before I begin, I will start by thanking…
I thank the gentleman for yielding. Mr. Speaker, I rise today in strong support of the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act. As a pharmacist for over four decades, I…
I think the Congress and the Navy made the right decision when we actually decided to also add additional SM-6 capability to the frigate as well, too, which will make it even that more capable as a multimission platform.





